Skip to main navigation
Skip to search
Skip to main content
MD Anderson Cancer Center Home
Help & FAQ
Home
Profiles
Research units
Equipment
Research output
Activities
Prizes
Search by expertise, name or affiliation
The potential for poly (ADP-ribose) polymerase inhibitors in cancer therapy
M. Javle
, N. J. Curtin
GI Medical Oncology
Research output
:
Contribution to journal
›
Review article
›
peer-review
78
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'The potential for poly (ADP-ribose) polymerase inhibitors in cancer therapy'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Poly(ADP-ribose) Polymerase Inhibitors
100%
iniparib
29%
DNA Repair
27%
DNA Damage
26%
Neoplasms
24%
Topoisomerase Inhibitors
23%
Single-Stranded DNA Breaks
20%
Recombinational DNA Repair
19%
Temozolomide
18%
Triple Negative Breast Neoplasms
18%
Phase III Clinical Trials
18%
Double-Stranded DNA Breaks
17%
Ionizing Radiation
15%
Ovarian Neoplasms
13%
Cisplatin
13%
Therapeutics
12%
Breast Neoplasms
9%
Mutation
8%
Pharmaceutical Preparations
6%